The Retinal Degeneration Fund (RD Fund) is a 501(c)(3) not-for-profit subsidiary of the Foundation Fighting Blindness. Launched in 2018 as the venture arm of the Foundation and with $72 million under management, the RD Fund focuses on making mission-related investments in companies with projects nearing clinical testing.

Contact Us

Companies interested in developing therapeutic technologies for IRDs and macular degeneration with programs that are about 18 months away from first-in-human studies should contact Rusty Kelley, Vice President, Investments & Alliances via the inquiry form below